Profile: Shanghai AoBo Bio-Pharmaceutical Technology Co., Ltd. is engaged in researching, developing, manufacturing and marketing of new pharmaceuticals and advanced intermediates and providing advanced technology services. We have the advantage of using multi-step synthesis technology and paying attention to researching and developing new technology through proprietary intellectual property rights. We specialize at developing drugs for antidepressants, antiviruses and cardiovascular purposes. We are also experienced in refining, separation and impurity control. We have currently researched and developed about twenty API projects including Temocapril HCL, with ten new projects in process.

Shanghai AoBo Bio-Pharmaceutical Technology Co., Ltd. was established in June 2004 and is located in “Chinese Medicine Valley”. Our R&D center is staffed with highly educated and experienced professionals and is 900 m2, with five synthesis labs, two scale-up pilot labs and one analytical lab.

Shanghai AoBo provides technical services for medical companies, chemical enterprises and trade companies at home and abroad. Our synthesis staff can provide technical services for research of organic chemistry in Aobo and can be engaged in routine organic reactions, anhydrous reactions, hydrogenation, oxidation, amination and more. We are fully equipped with more than ten glass reactors from 5L to 50L, two 20L rotary devaporizers combined with low-temperature cooling liquid circulating pump (30L, -40°), and ten 2L rotary devaporizers combined with low-temperature cooling liquid circulating pump (5L, -20°). We specialize in synthesis of reagents, pharmaceutical intermediates, reference standards and impurities from milligram scale to kilograms scale. Shanghai AoBo also has the production capacity for APIs and pharmaceutical intermediates with ranges from mere kilos to tens of tons per month using our parent company’s work shops.